同时发生的囊性纤维化和NSAID加剧的呼吸道疾病
S D Le Bon1, J Plojoux2, Y Coattrenec3
1Department of Otorhinolaryngology, Rhinology-Olfactology Unit, Service of Otorhinolaryngology-Head and Neck Surgery, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, Switzerland.
Rhinology
|May 23, 2025
概括
囊性纤维化 (CF) 患者经常患有慢性鼻炎 (CRS). 一个案例突出表明,与CF相关的CRS可以与NSAID加剧的呼吸道疾病 (NERD) 共存,需要双重治疗来控制症状.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 带有鼻的慢性鼻炎 (CRS) 影响6-57%的囊性纤维化 (CF) 患者.
- 像EPOS 2020这样的当前分类将CF相关的CRS分类为二级,非2型,与一般人群中常见的初级2型CRS不同.
- 现有的分类可能过于简化了CRS病因学,可能掩盖了多因素原因.
研究的目的:
- 举例来说,一个囊性纤维化患者同时患有慢性鼻炎和NSAID加重的呼吸道疾病.
- 强调推动CRS发展的多种潜在机制的潜力.
- 强调需要识别和管理复杂,多因素的CRS案例.
主要方法:
- 案例报告的呈现方式.
- 对CF,CRS和NSAID恶化呼吸道疾病 (NERD) 的临床表现和诊断标准的审查.
- 治疗干预和患者结果的描述.
主要成果:
- 该案例表明,一个CF患者经历了CRS与鼻.
- 这位患者还出现了NSAID恶化呼吸道疾病 (NERD).
- 通过两种不同的向治疗来实现有效的症状缓解,这些向治疗解决了这两种情况.
结论:
- 囊性纤维化中的慢性鼻炎可能是多因素的.
- 与CF相关的CRS和NSAID加剧的呼吸道疾病的同时存在是可能的.
- 针对性的双重治疗对于在CF患者中管理复杂的CRS表现至关重要.
相关概念视频
Cystic Fibrosis: Management
229
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
229
Cystic Fibrosis: Pathogenesis
378
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
378
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
471
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
471
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Drugs for Treatment of Constipation-Predominant IBS
353
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
353
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.3K


